Navigation Links
Electroporation of Yeast Artificial Chromosomes

Maren Bell and Robert Mortimer, Human Genome Center, Division of Cell and Molecular Biology, Lawrence Berkeley Laboratory, Berkeley, California 94720

Transformation of yeast with yeast artificial chromosomes (YACs) has traditionally been performed by a PEG-spheroplast procedure.1,2 However, the procedure is complicated, often unreliable, and transformation efficiencies are relatively low when compared to more recently developed transformation methods. An additional concern is that the smaller YACs of any given ligation mixture are cloned preferentially, therefore prior size fractionation with sucrose gradients to enrich for larger molecules, or treatment with spermidine to improve transformation efficiency of larger molecules, is required to obtain reasonable efficiencies with larger YACs. Several electroporation protocols have recently been reported for the transformation of Saccharomyces cerevisiae with supercoiled plasmids.3-6 In an attempt to improve the currently used YAC cloning procedure, we investigated the electroporation of S. cerevisiae strain AB1380 (Mat a, ade2-1, can1-100, lys2-1, trp1, ura3, his5, psi + ) with a 14.4 kb mini-YAC. Initial experiments showed transformation efficiencies two-fold better than those reported in a previously published YAC electroporation protocol.7

Materials and Methods
The YAC used in our experiments was constructed by the insertion of a 4.6 kb lambda MluI fragment into the MluI-SUP4 cloning site of pYAC-RC. 8 E. coli was transformed by the resulting 16.1 kb plasmid, the DNA was isolated, purified over cesium chloride, and restriction d igested with BamHI, thereby freeing the telomeres and resulting in a 14.4 kb linear DNA molecule. The restriction-digested DNA was microdialized (Millipore VS, 0.025 m) against TE (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) for 20 minutes, ethanol precipitated, and suspended in TE. The electroporation protocol used for our experiments was an adaptation of the one devised by Becker and Guarente.5 Exponentially growing cells were harvested by centrifugation, washed twice in water (4 C), once in 1 M sorbitol (4 C), and finally resuspended in a 2/3 pellet volume of 1 M sorbitol (4 C). A 40 l aliquot of cells was gently mixed with 1-5 l of DNA (0.1 g) just before electroporation. A Gene Pulser apparatus connected to the Pulse Controller accessory was used to pulse the sample in a chilled 0.2 cm cuvette, generating a pulse with a field strength of 7.5 kV/cm (1.5 kV), and a time constant (τ) of approximately 4.2 msec (25 F and 200 Ω). Ice cold 1 M sorbitol (1 ml) was added immediately after pulse delivery, and 150 l aliquots were plated on SD ura- plates. Transformants were visible after 3 days of incubation at 30 C.

Results and Discussion
Transformations with the small YAC have yielded approximately 700 transformants / g of DNA. Transformations with a supercoiled 5 kb plasmid yielded up to 1.6 x 104 transformants / g of DNA. A number of parameters were investigated in attempt to increase efficiencies. We found that 0.1 g of DNA in 1-5 l of TE or water was the optimum amount for 40 l of cells (5 x 108 cells). More DNA had an adverse effect on transformation efficiency and less DNA did not seem to saturate the reaction (Figure 3). Spermidine -treated DNA did not yield any transformants. Exponentially growing cells gave the most consistent and highest transformation efficiencies.

A possible problem associated with the high voltage electroporation of very large DNA fragments such as YACs is that the molecules are most likely sheared before they have a chance to enter the cell. Lower voltage experiments with the Gene Pulser apparatus (which generates an exponential decay pulse) have a less disruptive effect on large DNA molecules, but they also yield lower transformation efficiencies.3,4 The use of alternative waveforms may improve on current results.6 The S. cerevisiae strain used here (AB1380) is traditionally employed in PEG-spheroplast transformations and we do not know whether this strain is also a good electroporation candidate. Other strains that have proven to yield high transformation rates might further improve the results presented here.

1. Burke, D. T., Carle, G. F. and Olson, M. V., Science, 236, 806-812 (1987).

2. Burgers, P. M. J. and Percival, K. J., Anal. Biochem., 163, 391-397 (1987).

3. Delorme, E., Appl. Environ. Microbiol., 55, 2242-2246 (1989).

4. Simon, J. R. and McEntee, K., Biochem. Biophys. Res. Comm., 164, 1157-1164 (1990).

5. Becker, D. M. and Guarente, L., Meth. Enzymol., 194, 182- 186 (1990).

6. Meilhoc, E., Masson, J.-M. and Teissi, J., Bio/Technol., 8, 223-227 (1990).

7. Rech, E. L., Dobson, M. J., Davey, M. R. and Mulligan, B. J., Nucl. Acids Res., 18, 1313 (1990).

8. Marchuck, D., and Collins, F. S., Nucl. Acids Res., 16, 7743 (1988).

This work was supported by Bio-Rad Laboratories and by funds administered through DOE Contract No. DE-ACO3- 765F00098 to the Human Genome Center at Lawrence Berkeley Laboratory.

back to top


Page: All 1 2 3 4

Related biology technology :

1. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
2. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
3. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
4. Optimizing Chemical Transfection and Electroporation of siRNAs
5. High Throughput siRNA Electroporation
6. Electroporation of Primary Bone Marrow Cells
7. Production of Hybridomas by Electroporation
8. Transformation of Filamentous Fungi by High-Voltage Electroporation
9. Transgenic Zebrafish by Electroporation
10. Transient Gene Expression Following Single and Double Exponential Decay Electroporation Pulses
11. Epitope-Tagging Vectors for Functional Analysis in Yeast
Post Your Comments:

(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended September 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of iCo ... value enriching for this clinical program, but also ...
(Date:11/24/2015)... 24, 2015  Clintrax Global, Inc., a worldwide provider of clinical ... today announced that the company has set a new quarterly earnings ... on quarter growth posted for Q3 of 2014 to Q3 of ... Mexico , with the establishment of an ... --> United Kingdom and Mexico ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... Tech Association (MHTA) as one of only three finalists ... "Software – Small and Growing" category. The Tekne Awards honor ... have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... Daon, a global leader in mobile biometric ... new version of its IdentityX Platform , IdentityX ... have already installed IdentityX v4.0 and are ... FIDO UAF certified server component as an option ... features. These customers include some of the largest and ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... driving the explosion of technology-enabled health and wellness, and ... new book, The Internet of Healthy Things ... sensors or smartphones even existed, Dr. Kvedar, vice president, ... of health care delivery, moving care from the hospital ...
Breaking Biology News(10 mins):